To study the effect of Unani formulation of paste in acne vulgaris.

Clinical Study of Buthur Labaniyya (Acne vulgaris) and Therapeutic Evaluation of Unani Formulation of Dimad (Paste) in it’s management; An Open-label, block randomized, standard control study. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062474

Enrollment

Registered

2024-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Dimad (Paste): it is a classical Unani formulation taken from Tibbi Akbar. The formulation comprises of Alsi (Linum usitatissimum), Gul-e-Surkh (Rosa damascene Mill), Kalonji (Nigella s

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age group 15-60 years. 2. Clinically diagnosed patients of Buthur Labaniyya. 3. Patients Irrespective of the gender. 4. Patients with mild to moderate form of acne. 5. Patients who will agree to sign the informed consent form & follow the protocol.

Exclusion criteria

Exclusion criteria: 1. Patients with severe form of acne. 2. Diagnosed patients of PCOD. 3. Patients having local wound and infection on face. 4. Pregnant and lactating women. 5. Patients with systemic diseases like DM, CKD, Chronic liver diseases,and history of Thyroid diseases or malignancies. 6. Patients on corticosteroid therapy, anti-convulsant therapy or taking OCP. 7. Patients suffering from other concomitant diseases like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc.

Design outcomes

Primary

Measure	Time frame
1.Change in inflammatory lesions (Papules and Pustules) and non-inflammatory lesions (Open and Closed Comedones) (GAGS-Global Acne Grading System). 2) Change in the inflammatory (Papules and Pustules) lesions based on photographs of lesions. 3) Change in the quality of life of subjects based on the Dermatology Life Quality Index (DLQI).Timepoint: 0th day, 7th day, 14th day, 21st day, 28th day, 35th day, 42nd day	—

Measure

Time frame

1.Change in inflammatory lesions (Papules and Pustules) and non-inflammatory lesions (Open and Closed Comedones) (GAGS-Global Acne Grading System). 2) Change in the inflammatory (Papules and Pustules) lesions based on photographs of lesions. 3) Change in the quality of life of subjects based on the Dermatology Life Quality Index (DLQI).Timepoint: 0th day, 7th day, 14th day, 21st day, 28th day, 35th day, 42nd day

—

Secondary

Measure	Time frame
1) Effect on redness based on Clinical Erythema Assessment (CEA). 2) Effect on eruptions based on Simple Grading System by Indian Authors.Timepoint: 0th day, 7th day, 14th day, 21st day, 28th day, 35th day, 42nd day.	—

Countries

India

Contacts

Public ContactRifat Ara

Regional Research Institute of Unani Medicine (RRIUM), Srinagar

shameem.rather.SR@gmail.com7889584083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026